Medical Health Cluster

Farmacos

México en la quincena: proyecto de la NOM para residencias médicas, alertas de COFEPRIS, IMSS-Bienestar cumple un año

Se publica proyecto de NOM para residencias médicas La Secretaría de Salud publicó el proyecto de Norma Oficial Mexicana (NOM) para regular las residencias médicas (PROY-NOM-001-SSA-2023), el cual no presenta modificaciones sobre las características de las guardias de los médicos residentes respecto a la Norma Oficial de Emergencia publicada el […]

Read More

Paxlovid Expiration Dates Extended

Expiration dates have been extended from 9 months after manufacture to 12 months for 4 lots of the COVID-19 antiviral therapy Paxlovid, which consists of copackaged nirmatrelvir tablets and ritonavir tablets. The lot numbers and original expiration dates are listed on the FDA website. The nirmatrelvir-ritonavir lots were manufactured before the FDA […]

Read More

Nasal antiviral blocks SARS-CoV-2 infection in mice

SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed to produce antibodies to fight off the Omicron variant of SARS-CoV-2. And several combinations of […]

Read More

Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults — United States, September 22, 2021–February 6, 2022

What is already known about this topic? In preauthorization trials, adverse reactions were reported less frequently following a homologous COVID-19 mRNA vaccine booster dose than after receipt of the second primary dose. What is added by this report? Review of surveillance data found that local and systemic reactions were less […]

Read More

Un ‘viejo’ fármaco podría proteger contra la lesión pulmonar por Covid-19

Un fármaco que lleva más de 70 años en uso clínico puede proteger contra las lesiones pulmonares y el riesgo de coágulos sanguíneos en la Covid-19 grave y otros trastornos que causan daños inmunológicos en los pulmones, según un estudio preclínico de investigadores de Weill Cornell Medicine y Cold Spring Harbor Laboratory (Estados Unidos). Los investigadores, […]

Read More

Ivermectin as Potential COVID-19 Treatment Gets Studied at Duke University

Doctors at Duke University are leading a national study to test whether three drugs could effectively treat COVID-19 — including ivermectin — according to  The News & Observer. The study, which began last summer, is attempting to provide a comprehensive assessment of the controversial treatment. Ivermectin has been celebrated by some as a […]

Read More

La respuesta inmunitaria a coronavirus estacionales podría ofrecer protección frente a la Covid-19

Un grupo de investigación dirigido por Shin-ichiro Fujii, del Centro RIKEN de Ciencias Médicas Integrativas de Japón, ha descubierto que las personas con un determinado tipo de antígenos leucocitarios humanos (HLA) pueden ser capaces de montar una respuesta de células T asesinas contra el COVID-19, gracias a que las células T responden a una parte de la proteína de espiga del virus que también está […]

Read More

Moderna and Pfizer Vaccines Show Best Immune Response as Boosters

Seven different COVID-19 vaccines increase immunity when used as a booster for people who have had two doses of AstraZeneca/Oxford vaccine, and 6 vaccines provide immunity as boosters after 2 doses of Pfizer/BioNTech, a study has shown. However there were large variations in antibody and cellular immune responses between vaccines. […]

Read More